BMC Medicine Response to Reviewers: How to Write a Rebuttal That Survives Open Peer Review

BMC Medicine does not run private peer review. It uses transparent peer review with open identities and open reports. Two consequences follow, and both should change how you write.

First, authors know who the reviewers are during the review process. There is no anonymous shield on either side for the people in the conversation. Second, when a paper is accepted, the named reviewer reports accompany the published article, and BMC publishes a pre-publication history that contains the manuscript versions, the named reviewer reports, and your author responses. BioMed Central was the first publisher to post named reviewer reports as a pre-publication history for its medical series, and that has been the model since 2001.

That changes the stakes of your rebuttal. At a single-blind journal, a sloppy or defensive response costs you one editor's goodwill in private. At BMC Medicine, the same response is a citable, permanent document that any future reader can open next to your paper. Because reviewers know their named report will be published, BMC Medicine reports tend to be long and detailed, often running thousands of words, so the point-by-point response that answers them has to be thorough in kind.

Beyond the open model, BMC Medicine's editorial bar shapes what reviewers ask for. The journal is the flagship general-medicine title of the BMC series, and its reviewers consistently press two demands: that the finding has broad clinical relevance across specialties rather than interest to one niche, and that the manuscript adheres to the relevant reporting guideline (CONSORT, STROBE, or PRISMA 2020) with the text matching the checklist line for line.

A response to reviewers that does not engage both of those, plus the open-record reality, is writing to the wrong audience.

Source: BMC Medicine / Springer Nature peer-review and submission documentation, EQUATOR Network reporting standards, and Manusights review of BMC Medicine resubmissions (accessed June 2026).

The format is not cosmetic. A structured, point-by-point letter with a clearly marked-up manuscript is what lets a named reviewer re-check their concern quickly, and a quick re-check is what gets you a clean acceptance instead of a third round. Respond to every comment, including the ones that recommend rejection, and if you genuinely cannot make a change, say so and explain why rather than going silent on it.

A practical note on the mechanics. BMC Medicine handles submissions and revisions through its Editorial Manager portal at Editorial Manager submission portal, where you upload the revised manuscript, the response document, and a clean and a tracked-changes version.

When you rewrite the Abstract to make the broad-relevance case, keep it within the journal's 350-word structured-abstract limit, and remember the main text runs to a roughly 5,000-word cap that editors can flex with approval, so a longer response document does not buy you more room in the manuscript itself.

Because BMC Medicine reports are named and published, tone is not a soft skill here, it is part of the public record. The fix is almost never to be more deferential, it is to be more specific. These pairs show the difference.

The throughline: replace assertion with location. A reviewer who can verify your change in five seconds is a reviewer who recommends acceptance.

Make it visually obvious where the reviewer's words end and yours begin. The convention BMC Medicine reviewers and editors expect is to reproduce each reviewer comment in a distinct style (bold, italic, or a shaded text box) and to set your author response in plain text directly beneath it, ideally on a new line with a clear "Response:" label.

Using a different font weight or color for reviewer text versus author response is the simplest way to keep a long, multi-round document readable. Do not blend the reviewer's comment and your reply into one paragraph, because once the document is published as the pre-publication history, an unclear boundary between comment and response confuses every future reader.

In our pre-submission review work with BMC Medicine submissions, the manuscripts that come back from revision in good shape and the ones that get rejected on revision split along a small number of named patterns. Three of these are the requests BMC Medicine reviewers raise most often, and the fourth is the response-writing failure that turns a fixable revision into a rejection. Each is testable against your own response document before you upload it.

Pattern 1: the reporting-checklist gap the reviewer keeps reopening. This is the most common reason a BMC Medicine revision drags into a second or third round. The author attaches the CONSORT, STROBE, or PRISMA 2020 checklist, but the manuscript text still omits the underlying item, so a named reviewer flags it again.

Across our BMC Medicine pre-submission reviews, the recurring tell is a CONSORT checklist that points to "see Methods" for allocation concealment or blinding while the Methods section never actually describes them, or a PRISMA 2020 review missing its full search strategy and PROSPERO registration in the text.

The fix is to add the item to the text, then write a response that names the exact reporting item and the page and line where it now appears, so the reviewer can close the comment instead of reopening it.

Pattern 2: the broad-relevance comment answered with more specialty detail. BMC Medicine reviewers screen for whether a finding matters across general medicine, not only inside one specialty. When a reviewer asks the authors to make the case for broad relevance, the weak response we see most often doubles down on subspecialty depth instead, adding more mechanistic or field-specific detail. That answers a question the reviewer did not ask.

The response that works rewrites the Abstract and the first paragraph of the Discussion to state the cross-specialty implication explicitly, then points the reviewer to those exact lines. If the finding genuinely does not generalize, a BMC series specialty journal is the honest home, and a transfer is faster than arguing relevance the paper does not have.

Pattern 3: the data-availability and statistical-analysis statement left thin. A frequent BMC Medicine reviewer request is to strengthen the data-availability statement and the description of the statistical analysis.

In our BMC Medicine pre-submission reviews, the version that triggers a follow-up comment is a data-availability statement that says "available on request" with no repository, no accession number, and no stated access conditions, or a statistical-analysis section that names tests without specifying the pre-specified primary analysis and how missing data were handled.

Fix both in the manuscript, then document the change with page and line references and the repository identifier, because every reputable journal downstream will ask for the same thing.

Pattern 4: the response that asserts a change without a verifiable location. This is the one response-writing failure that converts a routine revision into a rejection on revision. We repeatedly see otherwise sound revisions weakened by responses that say "we have addressed this" or "we have updated the manuscript" with no page or line reference.

Under open peer review the cost is doubled: a named reviewer cannot verify the edit, the editor cannot adjudicate the disagreement, and the unverifiable claim becomes part of the permanent public record if the paper is later accepted. The discipline that prevents it is mechanical: every single response ends with the page and line where the reviewer can see the change for themselves. A [BMC Medicine point-by-point response check](/ai-review?

target_journal=BMC%20Medicine&primary_concern=rebuttal&source_blog=bmc-medicine-response-to-reviewers) flags responses that claim a change without a verifiable location, missing reporting-checklist items, and unaddressed reviewer comments before an editor sees them.

The practical takeaway: patterns 1, 2, and 3 are manuscript fixes you document in the response, and pattern 4 is the response-writing discipline that makes the other three legible to a named reviewer. Get all four right and the open-record model works in your favor, because a clean, verifiable response published next to your paper reads as a sign of careful work.

BMC Medicine is fast at the front end and conventional once a paper is in real review. The median time from submission to first editorial decision is 3 days, which is the triage signal, and the median from submission to acceptance is 161 days, which is the full reviewed-paper path including your revision rounds. Your response to reviewers sits inside that gap, and how you write it is the variable you actually control.

Most of your own time goes to three pieces of work. Reading and clustering the named reviewer reports takes one to three days, longer because transparent peer review tends to produce long, detailed reports. Running any reviewer-requested new analyses can take one to six weeks, depending on whether reviewers asked for additional data. Drafting the point-by-point response itself usually takes one to two weeks, driven by the number of comments and how thoroughly you cite each change. Co-author sign-off adds about a week.

Source: Springer Nature journal metrics for BMC Medicine (first decision and acceptance medians) plus Manusights review of BMC Medicine resubmissions (accessed June 2026).

The part that stalls is re-review, and the lever on it is verifiability. A response where every change is pinned to a page and line lets a named reviewer re-check in one pass. A response that forces the reviewer to hunt invites a second round, and at a 161-day median, a saved round is real time.

A revise decision is an invitation, not a guarantee. BMC Medicine does not publish a revision-stage rejection rate, and the journal's overall acceptance rate is estimated at roughly 10 to 15 percent, so a meaningful share of revised papers still do not make it. Knowing the failure modes is how you avoid them.

Most rejection-on-revision outcomes we see trace to the same causes. The response argues away a core concern instead of addressing it, most often a reviewer's doubt about broad clinical relevance that the author answers with more specialty detail. New analyses the reviewers explicitly requested were not run, so a named reviewer's central question is left open. Or the response is generic, claiming changes without page and line references, which under open peer review leaves the reviewer unable to verify anything and the editor unable to adjudicate.

There is also a tone trap unique to the open model. Because reviewers are named, a sarcastic or dismissive reply does not just annoy one anonymous reader, it becomes a visible, permanent part of the record if the paper is accepted. Reasoned disagreement is fine and expected, but it has to be argued on the science and the journal's broad-relevance bar, not on the reviewer's competence.

If a reviewer's core concern about relevance or methodology is correct and you cannot fix it, the honest move is a transfer to a BMC series specialty journal rather than a rebuttal that pretends the gap is not there. The majority of avoidable rejection-on-revision cases at BMC Medicine come down to a single habit: claiming a change the reviewer cannot verify.